Kim Paul insider trades
Kim Paul has filed 83 Form 4s with the SEC that we hold, for Fulgent Genetics, Inc. (FLGT) (CFO and Treasurer) and Exagen INC. (XGN) (Director). Across all of them we count 1 purchase worth $1.6M and 27 sales worth $2.5M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 100,000 shares of Fulgent Genetics, Inc. worth $1.6M, dated 2025-03-05. The first filing on our record is dated 2021-08-05 and the latest 2026-09-03.
Fulgent Genetics, Inc. (FLGT)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-08-16 | S, sale reported on Form 4 | 1,682 | $160.0K | 2021-08-18 |
| 2021-09-02 | S, sale reported on Form 4 | 607 | $57.2K | 2021-09-07 |
| 2021-11-16 | S, sale reported on Form 4 | 455 | $43.5K | 2021-11-18 |
| 2021-11-16 | S, sale reported on Form 4 | 1,214 | $115.9K | 2021-11-18 |
| 2021-11-18 | S, sale reported on Form 4 | 500 | $48.7K | 2021-11-18 |
| 2021-11-19 | S, sale reported on Form 4 | 10,263 | $979.5K | 2021-11-23 |
| 2021-12-02 | S, sale reported on Form 4 | 620 | $51.6K | 2021-12-06 |
| 2022-03-03 | S, sale reported on Form 4 | 454 | $25.6K | 2022-03-04 |
| 2022-05-16 | S, sale reported on Form 4 | 866 | $46.2K | 2022-05-18 |
| 2022-05-16 | S, sale reported on Form 4 | 325 | $17.3K | 2022-05-18 |
| 2022-06-02 | S, sale reported on Form 4 | 415 | $22.9K | 2022-06-06 |
| 2022-08-17 | S, sale reported on Form 4 | 1,945 | $95.1K | 2022-08-19 |
| 2022-09-06 | S, sale reported on Form 4 | 662 | $27.4K | 2022-09-08 |
| 2022-11-16 | S, sale reported on Form 4 | 1,306 | $46.9K | 2022-11-18 |
| 2022-11-16 | S, sale reported on Form 4 | 490 | $17.6K | 2022-11-18 |
| 2022-12-02 | S, sale reported on Form 4 | 653 | $23.1K | 2022-12-06 |
| 2023-05-17 | S, sale reported on Form 4 | 921 | $32.7K | 2023-05-19 |
| 2023-05-17 | S, sale reported on Form 4 | 345 | $12.2K | 2023-05-19 |
| 2023-06-02 | S, sale reported on Form 4 | 1,403 | $56.5K | 2023-06-06 |
| 2023-08-17 | S, sale reported on Form 4 | 491 | $16.6K | 2023-08-21 |
| 2023-08-17 | S, sale reported on Form 4 | 1,307 | $44.3K | 2023-08-21 |
| 2023-08-28 | S, sale reported on Form 4 | 10,299 | $346.3K | 2023-08-30 |
| 2023-09-07 | S, sale reported on Form 4 | 1,492 | $46.9K | 2023-09-11 |
| 2023-11-16 | S, sale reported on Form 4 | 1,307 | $35.6K | 2023-11-20 |
| 2023-12-04 | S, sale reported on Form 4 | 1,437 | $39.6K | 2023-12-06 |
| 2024-08-27 | S, sale reported on Form 4 | 733 | $16.7K | 2024-08-29 |
| 2024-09-03 | S, sale reported on Form 4 | 1,674 | $36.8K | 2024-09-05 |
| 2025-03-05 | P, purchase reported on Form 4 | 100,000 | $1.6M | 2025-03-05 |
Exagen INC. (XGN)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1253820) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms